Updates from ASCO 2016: Immunotherapy for sarcoma shows a signal!

Greetings from Chicago, where once again, immunotherapy remains the highlight of most ASCO presentations.  This year was particularly exciting, as we finally got to see the preliminary results of the first clinical trials of checkpoint inhibitors for sarcomas.  So, I will update all of you on the most recent data, explain how we still have more … More Updates from ASCO 2016: Immunotherapy for sarcoma shows a signal!

Clinical Trials: What you should know to make an informed choice about your therapy.

This is a guinea pig. Greetings readers, My 282 page grant finally went in Monday – and so now I finally have some spare writing quota to return to the blog!  Today’s topic – everything you ever needed to know about clinical trials.  The goal is to clear up some misconceptions, and also to help … More Clinical Trials: What you should know to make an informed choice about your therapy.